MwanzoORCHPHARMA • NSE
add
Orchid Pharma Ltd
Bei iliyotangulia
₹ 1,336.40
Bei za siku
₹ 1,335.00 - ₹ 1,420.00
Bei za mwaka
₹ 713.00 - ₹ 1,997.40
Thamani ya kampuni katika soko
71.49B INR
Wastani wa hisa zilizouzwa
elfu 89.89
Uwiano wa bei na mapato
58.83
Mgao wa faida
-
Ubadilishanaji wa msingi
NSE
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (INR) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 2.23B | 12.05% |
Matumizi ya uendeshaji wa biashara | 698.25M | 14.56% |
Mapato halisi | 272.36M | 37.53% |
Kiwango cha faida halisi | 12.23 | 22.79% |
Mapato kwa kila hisa | 5.37 | — |
EBITDA | 302.47M | 30.11% |
Asilimia ya kodi ya mapato | — | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (INR) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 2.44B | 384.25% |
Jumla ya mali | 16.35B | 9.59% |
Jumla ya dhima | 4.11B | 6.94% |
Jumla ya hisa | 12.24B | — |
hisa zilizosalia | 50.72M | — |
Uwiano wa bei na thamani | 5.54 | — |
Faida inayotokana na mali | — | — |
Faida inayotokana mtaji | 4.03% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (INR) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 272.36M | 37.53% |
Pesa kutokana na shughuli | — | — |
Pesa kutokana na uwekezaji | — | — |
Pesa kutokana na ufadhili | — | — |
Mabadiliko halisi ya pesa taslimu | — | — |
Mtiririko huru wa pesa | — | — |
Kuhusu
Orchid Pharma Limited is an Indian pharmaceutical company based in Chennai, founded on 1 July 1992. As of 2024, it was among the top fortune 500 Indian companies by market capitalization. Orchid Pharma is the only pharma company in India to have discovered a New Drug Enmetazobactam which is now approved in United States, Europe and India. Wikipedia
Ilianzishwa
1992
Tovuti
Wafanyakazi
871
